• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Clinical features, treatments and preventions for newborns with pandemic influenza A (H1N1) 2009

tetano

Editor, Senior Moderator
Nippon Rinsho. 2010 Sep;68(9):1656-8.
[Clinical features, treatments and preventions for newborns with pandemic influenza A (H1N1) 2009]

[Article in Japanese]

Morioka I, Arakawa S, Matsuo M.

Division of Infection Control and Prevention, Kobe University Hospital.
Abstract

Newborns should be considered to be at high risk of developing complications of novel influenza like pandemic influenza A (H1N1) 2009, because maternal antibodies are not transferred via crossing the placenta. In Japan, some newborns with pandemic influenza A (H1N1) 2009 appeared non-specific symptoms, such as fever, poor activity and sucking, and apnea. A Japanese newborn infected with pandemic influenza A (H1N1) 2009 combined with S. pneumoniae, developed severe pneumonia by which a mechanical ventilation was initiated. Orally oseltamivir(3-4 mg/kg/dose twice a day for 5 days) was used for treatments of flu-infected newborns. Contact and droplet precautions were very important measures to prevent transmission of pandemic influenza A (H1N1) 2009 virus to newborns.

PMID: 20845743 [PubMed - in process]

http://www.ncbi.nlm.nih.gov/pubmed/20845743
 
Back
Top Bottom